5631

    0

    PAR

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PAR DRUGS AND CHEM LTD Share Price Today

    PAR DRUGS AND CHEM LTD is currently trading at ₹92, up by ₹2.41 from the previous close. The stock touched an intraday high of ₹92.50 and a low of ₹87.61 during the latest trading session. Over the past one year, PAR DRUGS AND CHEM LTD has delivered a loss of 5.0%, while the stock has gained 2.01% in the last one month.

    PAR DRUGS AND CHEM LTD performance

    Today’s low Today’s high
    ₹ 87.61 ₹ 92.50
    ₹ 91.68
    52 week low 52 week high
    ₹ 78.05 ₹ 122.43
    ₹ 91.68
    Open Price ₹ 87.61
    Prev. Close ₹ 89.58
    Volume (Shares) 6346.00
    Total traded value ₹ 5.81
    Upper Circuit ₹ 107.49
    Lower Circuit ₹ 71.67
    info

    Investment Returns

    Over 1 Month 2.01% Over 3 Months -2.27% Over 6 Months -3.96% Over 1 Year -5.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PAR DRUGS AND CHEM LTD fundamentals


    • Market cap (Cr) 112.80
    • P/E Ratio (TTM) 8.41
    • Beta 1.10
    • Book Value / share 91.01
    • Return on equity 14.47%
    • EPS (TTM) 10.65
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.85
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    PAR DRUGS AND CHEM LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 19.61
    Operating Expense 19.14
    Net Profit 0.85
    Net Profit Margin (%) 4.33
    Earnings Per Share (EPS) 0.69
    EBITDA 1.80
    Effective Tax Rate (%) -2.40
    Particulars DEC 2025 (Values in Cr)
    Revenue 29.34
    Operating Expense 24.22
    Net Profit 4.80
    Net Profit Margin (%) 16.35
    Earnings Per Share (EPS) 3.90
    EBITDA 7.38
    Effective Tax Rate (%) 25.46
    Particulars SEP 2025 (Values in Cr)
    Revenue 28.66
    Operating Expense 23.58
    Net Profit 4.13
    Net Profit Margin (%) 14.41
    Earnings Per Share (EPS) 3.36
    EBITDA 6.53
    Effective Tax Rate (%) 25.58
    Particulars JUN 2025 (Values in Cr)
    Revenue 26.05
    Operating Expense 23.41
    Net Profit 3.33
    Net Profit Margin (%) 12.78
    Earnings Per Share (EPS) 2.70
    EBITDA 5.40
    Effective Tax Rate (%) 25.66
    Particulars MAR 2025 (Values in Cr)
    Revenue 22.33
    Operating Expense 20.84
    Net Profit 1.65
    Net Profit Margin (%) 7.38
    Earnings Per Share (EPS) 1.34
    EBITDA 3.21
    Effective Tax Rate (%) 27.63
    Particulars MAR 2026 (Values in Cr)
    Revenue 103.66
    Operating Expense 90.36
    Net Profit 13.11
    Net Profit Margin (%) 12.64
    Earnings Per Share (EPS) 10.65
    EBITDA 21.13
    Effective Tax Rate (%) 24.21
    Particulars MAR 2025 (Values in Cr)
    Revenue 100.97
    Operating Expense 85.20
    Net Profit 13.36
    Net Profit Margin (%) 13.23
    Earnings Per Share (EPS) 10.86
    EBITDA 21.65
    Effective Tax Rate (%) 25.50
    Particulars MAR 2024 (Values in Cr)
    Revenue 95.64
    Operating Expense 76.37
    Net Profit 14.50
    Net Profit Margin (%) 15.16
    Earnings Per Share (EPS) 11.78
    EBITDA 23.07
    Effective Tax Rate (%) 25.71
    Particulars MAR 2023 (Values in Cr)
    Revenue 95.75
    Operating Expense 80.89
    Net Profit 11.33
    Net Profit Margin (%) 11.83
    Earnings Per Share (EPS) 9.21
    EBITDA 18.44
    Effective Tax Rate (%) 24.86
    Particulars MAR 2022 (Values in Cr)
    Revenue 75.07
    Operating Expense 62.55
    Net Profit 9.21
    Net Profit Margin (%) 12.26
    Earnings Per Share (EPS) 7.49
    EBITDA 16.43
    Effective Tax Rate (%) 27.48
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 80.44
    ROE % 14.47
    ROCE % 19.48
    Total Debt to Total Equity 0.00
    EBITDA Margin 19.09
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 69.59
    ROE % 18.49
    ROCE % 25.01
    Total Debt to Total Equity 0.00
    EBITDA Margin 21.50
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 57.90
    ROE % 17.28
    ROCE % 23.11
    Total Debt to Total Equity 0.00
    EBITDA Margin 19.26
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 48.66
    ROE % 16.43
    ROCE % 21.70
    Total Debt to Total Equity 0.07
    EBITDA Margin 19.36
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 84.87
    ROE % 21.72
    ROCE % 24.78
    Total Debt to Total Equity 0.15
    EBITDA Margin 23.45
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 27.57
    Total Assets 119.39
    Total Liabilities 119.39
    Total Equity 98.97
    Share Outstanding 1
    Price to Book Ratio 1.06
    Return on Assets (%) 11.18
    Return on Capital (%) 13.5
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.65
    Total Assets 101.61
    Total Liabilities 101.61
    Total Equity 85.63
    Share Outstanding 1
    Price to Book Ratio 3.10
    Return on Assets (%) 14.27
    Return on Capital (%) 16.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 22.24
    Total Assets 88.86
    Total Liabilities 88.86
    Total Equity 71.23
    Share Outstanding 1
    Price to Book Ratio 2.42
    Return on Assets (%) 12.75
    Return on Capital (%) 15.91
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 16.20
    Total Assets 78.69
    Total Liabilities 78.69
    Total Equity 59.87
    Share Outstanding 1
    Price to Book Ratio 3.28
    Return on Assets (%) 11.70
    Return on Capital (%) 15.39
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 21.16
    Total Assets 76.38
    Total Liabilities 76.38
    Total Equity 52.21
    Share Outstanding 0
    Price to Book Ratio 1.46
    Return on Assets (%) 15.20
    Return on Capital (%) 19.4
    Particulars MAR 2025 (Values in Cr)
    Net Income 17.92
    Cash from Operations 20.67
    Cash from Investing -25.23
    Cash from Financing 0.00
    Net change in Cash -9.07
    Free Cash Flow 21.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 19.51
    Cash from Operations 24.60
    Cash from Investing -5.83
    Cash from Financing 0.00
    Net change in Cash 14.41
    Free Cash Flow 30.68
    Particulars MAR 2023 (Values in Cr)
    Net Income 15.07
    Cash from Operations 17.64
    Cash from Investing -7.33
    Cash from Financing 0.00
    Net change in Cash 6.03
    Free Cash Flow 25.27
    Particulars MAR 2022 (Values in Cr)
    Net Income 12.70
    Cash from Operations 10.73
    Cash from Investing -3.01
    Cash from Financing -9.55
    Net change in Cash -4.95
    Free Cash Flow 13.94
    Particulars MAR 2021 (Values in Cr)
    Net Income 14.72
    Cash from Operations 15.67
    Cash from Investing 0.05
    Cash from Financing 1.64
    Net change in Cash 13.78
    Free Cash Flow 20.72
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD. 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 411.65 18.16 2.97 1211.53 256.40 415.70
    GLAXOSMITHKLINE PHARMACEUTICAL 2435.50 42.88 18.19 41258.84 2088.00 3301.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 521.10 56.34 4.78 5526.59 118.35 552.90

    PAR DRUGS AND CHEM LTD shareholding pattern

    Holding
    26.59%
    73.4%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    PAR DRUGS AND CHEM LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    91.68 2.34 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 89.80
    • 26 Days 90.40
    • 10 Days 90.20
    • 50 Days 90.40
    • 12 Days 90.30
    • 100 Days 91.30
    • 20 Days 90.40
    • 200 Days 98.80
    89.87 PIVOT
    First Support 88.76 First Resistance 90.70 Second Support 87.93 Second Resistance 91.81 Third Support 86.82 Third Resistance 92.64
    RSI 47.86 ADX 11.23 MACD -0.15 Williams % R -74.20 Commodity Channel Index (CCI) -54.70
    Date 2026-07-10 Week 2387.00 Same Day 1553.00 Month 6023.00
    1 Year 1.10 3 Year 0.88
    Over 1 Month
    2.01% down
    Over 1 Year
    -5.00% down
    Over 3 Months
    -2.27% down
    Over 3 Years
    -23.81% down
    Over 6 Months
    -3.96% down
    Over 5 Years
    -3.84% down

    PAR DRUGS AND CHEM LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Nov 2021 1.25 Interim 23 Nov 2021 Equity shares
    10 Jul 2020 1.25 Final 14 Jul 2020 Equity shares
    22 Nov 2019 1.25 Interim 25 Nov 2019 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Apr 2021 27 Apr 2021 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Par Drugs & Chemicals Ltd?

    Answer Field

    Par Drugs & Chemicals Ltd share price is for NSE ₹ 92.00 & for BSE ₹ 0.00 as on Jul 13 2026 03:29 PM.

    What is the Market Cap of Par Drugs & Chemicals Ltd Share?

    Answer Field

    The market cap of Par Drugs & Chemicals Ltd for NSE ₹ 112.80 & for BSE ₹ 0.00 as on Jul 13 2026 03:29 PM.

    What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?

    Answer Field

    The 52 Week High and Low of Par Drugs & Chemicals Ltd for NSE is ₹ 122.43 and ₹ 78.05 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Par Drugs & Chemicals Ltd?

    Answer Field

    The 1 year returns on the stock has been -5.00%.

    What is the P/E Ratio of Par Drugs & Chemicals Ltd Share?

    Answer Field

    As on Jul 13 2026 03:29 PM the price-to-earnings (PE) ratio for Par Drugs & Chemicals Ltd share is 8.41.

    What is the PB ratio of Par Drugs & Chemicals Ltd Share?

    Answer Field

    As on Jul 13 2026 03:29 PM, the price-to-book (PB) ratio for Par Drugs & Chemicals Ltd share is 91.01.

    How to Buy Par Drugs & Chemicals Ltd Share?

    Answer Field

    You can trade in Par Drugs & Chemicals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Par Drugs & Chemicals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Par Drugs & Chemicals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Par Drugs & Chemicals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |